952 Phase II trial of AV-GBM-1: dendritic cell vaccine pulsed with lysate enriched for autologous tumor-initiating cell antigens in the treatment of patients with newly diagnosed glioblastoma
Bota, Daniela, Piccioni, David, Duma, Christopher, LaRocca, Renato, Kesari, Santosh, Abedi, Mehrdad, Carrillo, Jose, Aiken, Robert, Hsu, Frank, Kong, Xiaotang, Taylor, Thomas, Hsieh, Candace, Nistor, Gabriel, Dillman, Robert
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
NI-32ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION
Hardy, Anthony, Prins, Robert, Kong, Xiaotang, Woodworth, Davis, Pope, Whitney, Yong, William, Cloughesy, Timothy, Liau, Linda, Ellingson, Benjamin
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article
NI-32 ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION
Hardy, A., Prins, R., Kong, X., Woodworth, D., Pope, W., Yong, W., Cloughesy, T., Liau, L., Ellingson, B.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article